Newspaper Publication of unaudited financial results for quarter and half year ended 30-09-2025
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has published its unaudited financial results for Q2 FY26 (quarter ended Sept 30, 2025) and H1 FY26 in the Financial Express (English) and Punjabi Jagran (Punjabi) newspapers on November 15, 2025, as required under SEBI LODR regulations. On a standalone basis, the company reported a net profit after tax of Rs. 1,411.64 Lacs for Q2 FY26, up roughly 66% from Rs. 848.52 Lacs in Q2 FY25. Standalone net profit for H1 FY26 stood at Rs. 2,604.86 Lacs. On a consolidated basis, total income from operations for Q2 FY26 was Rs. 11,105.10 Lacs versus Rs. 8,903.44 Lacs in Q2 FY25, while net profit before tax rose to Rs. 1,845.05 Lacs (vs Rs. 1,255.39 Lacs YoY). Basic and diluted EPS for H1 FY26 stood at Rs. 38.36. The results were reviewed by the Audit Committee and approved by the Board on November 13, 2025.
The numbers point to strong year-on-year growth in both revenue and profit, which is a positive signal for shareholders. However, this filing is a routine regulatory newspaper republication of results already filed with BSE, so it is unlikely to trigger a fresh stock reaction on its own.